 SAN FRANCISCO, Feb. 17, 2022 PRNewswire -- Nektar Therapeutics Nasdaq: NKTR will announce its financial results for the fourth quarter and year-ended December 31, 2021 on Monday, February 28, 2022, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. 